InBriefs May 6, 2020 Lancet Neurology: Teens and adults on SPINRAZA® showed clinically meaningful improvement in motor function Read More March 30, 2020 Ionis Statement on COVID-19 Read More February 27, 2020 Ionis and partner highlight tominersen (formerly known as IONIS-HTTRx and RG6042) data at annual Huntington’s disease drug discovery conference Read More
May 6, 2020 Lancet Neurology: Teens and adults on SPINRAZA® showed clinically meaningful improvement in motor function Read More
February 27, 2020 Ionis and partner highlight tominersen (formerly known as IONIS-HTTRx and RG6042) data at annual Huntington’s disease drug discovery conference Read More